Tags: Novartis | Drugs | Profit | Earnings

Novartis Profit Rises 6.7% Thanks to New Drugs

Wednesday, 24 Apr 2013 08:08 AM

Swiss pharmaceutical company Novartis AG has reported a 6.7 percent increase in profit for the first quarter, boosted by new products and emerging markets.

Novartis says its net profit rose to $2.42 billion from $2.27 billion in the same period last year.

The Basel-based company said in a statement Wednesday that the increase — a turnaround from the 18 percent earnings drop in the first quarter of 2012 — reflected new product launches, strength in emerging markets and E.U. and U.S. drug approvals to offset patent expirations.

But the quarter was notably marked by the controversy over Novartis' outgoing board chairman, Daniel Vasella, who touched off widespread anger for his whopping 72 million Swiss francs ($77 million) severance package that he later declined due to the Swiss public's outcry.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

 
1Like our page
2Share
Companies
Swiss pharmaceutical company Novartis AG has reported a 6.7 percent increase in profit for the first quarter, boosted by new products and emerging markets.Novartis says its net profit rose to $2.42 billion from $2.27 billion in the same period last year.The Basel-based...
Novartis,Drugs,Profit,Earnings
127
2013-08-24
Wednesday, 24 Apr 2013 08:08 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved